Validation Data Gallery
Tested Applications
Positive WB detected in | human plasma |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:6000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
55164-1-AP targets STX1A in WB, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | Peptide 相同性解析による交差性が予測される生物種 |
Full Name | syntaxin 1A (brain) |
Calculated molecular weight | 33 kDa |
Observed molecular weight | 35 kDa |
GenBank accession number | NM_004603 |
Gene Symbol | STX1A |
Gene ID (NCBI) | 6804 |
RRID | AB_3086433 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
UNIPROT ID | Q16623 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol{{ptg:BufferTemp}}7.3 |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
Syntaxins are a family of transmembrane proteins that belong to the SNARE complex (PMID: 11737951). In conjunction with other SNAREs and with the cytoplasmic NSF and SNAP proteins, syntaxins mediate vesicle fusion in diverse vesicular transport processes along the exocytic and endocytic pathways (PMID: 11737951). Syntaxin 1A (STX1A) and 1B (STX1B), two closely related isoforms of syntaxin 1, are involved in synaptic vesicle docking and fusion during neurotransmitter release (PMID: 7690687; 1321498; 18691641). Syntaxin 1A is associated with a variety of neurological diseases, including epilepsy, attention deficit hyperactivity disorder (ADHD), migraine, etc (PMID: 26918652; 25445064; 22250207). This antibody recognizes human STX1A.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for STX1A antibody 55164-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |